BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28988748)

  • 1. Structural and Functional Implications of Human Transforming Growth Factor β-Induced Protein, TGFBIp, in Corneal Dystrophies.
    García-Castellanos R; Nielsen NS; Runager K; Thøgersen IB; Lukassen MV; Poulsen ET; Goulas T; Enghild JJ; Gomis-Rüth FX
    Structure; 2017 Nov; 25(11):1740-1750.e2. PubMed ID: 28988748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-Induced Deamidation of Corneal Dystrophy-Related Transforming Growth Factor β-Induced Protein.
    Nielsen NS; Juhl DW; Poulsen ET; Lukassen MV; Poulsen EC; Risør MW; Scavenius C; Enghild JJ
    Biochemistry; 2017 Dec; 56(49):6470-6480. PubMed ID: 29140698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization.
    Underhaug J; Koldsø H; Runager K; Nielsen JT; Sørensen CS; Kristensen T; Otzen DE; Karring H; Malmendal A; Schiøtt B; Enghild JJ; Nielsen NC
    Biochim Biophys Acta; 2013 Dec; 1834(12):2812-22. PubMed ID: 24129074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.
    Karring H; Poulsen ET; Runager K; Thøgersen IB; Klintworth GK; Højrup P; Enghild JJ
    Mol Vis; 2013; 19():861-76. PubMed ID: 23592924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal dystrophies.
    Clout NJ; Hohenester E
    Mol Vis; 2003 Sep; 9():440-8. PubMed ID: 14502125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.
    Runager K; Basaiawmoit RV; Deva T; Andreasen M; Valnickova Z; Sørensen CS; Karring H; Thøgersen IB; Christiansen G; Underhaug J; Kristensen T; Nielsen NC; Klintworth GK; Otzen DE; Enghild JJ
    J Biol Chem; 2011 Feb; 286(7):4951-8. PubMed ID: 21135107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.
    Sørensen CS; Runager K; Scavenius C; Jensen MM; Nielsen NS; Christiansen G; Petersen SV; Karring H; Sanggaard KW; Enghild JJ
    Biochemistry; 2015 May; 54(19):2943-56. PubMed ID: 25910219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Events in the Amyloid Formation of the A546T Mutant of Transforming Growth Factor β-Induced Protein in Corneal Dystrophies Compared to the Nonfibrillating R555W and R555Q Mutants.
    Koldsø H; Andersen OJ; Nikolajsen CL; Scavenius C; Sørensen CS; Underhaug J; Runager K; Nielsen NC; Enghild JJ; Schiøtt B
    Biochemistry; 2015 Sep; 54(36):5546-56. PubMed ID: 26305369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASIK surgery of granular corneal dystrophy type 2 patients leads to accumulation and differential proteolytic processing of transforming growth factor beta-induced protein (TGFBIp).
    Poulsen ET; Nielsen NS; Jensen MM; Nielsen E; Hjortdal J; Kim EK; Enghild JJ
    Proteomics; 2016 Feb; 16(3):539-43. PubMed ID: 26864644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serine protease HtrA1 cleaves misfolded transforming growth factor β-induced protein (TGFBIp) and induces amyloid formation.
    Poulsen ET; Nielsen NS; Scavenius C; Mogensen EH; Risør MW; Runager K; Lukassen MV; Rasmussen CB; Christiansen G; Richner M; Vorum H; Enghild JJ
    J Biol Chem; 2019 Aug; 294(31):11817-11828. PubMed ID: 31197037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two phenotypically distinct lattice corneal dystrophies caused by mutations in the transforming growth factor beta induced (TGFBI) gene.
    Poulsen ET; Runager K; Risør MW; Dyrlund TF; Scavenius C; Karring H; Praetorius J; Vorum H; Otzen DE; Klintworth GK; Enghild JJ
    Proteomics Clin Appl; 2014 Apr; 8(3-4):168-77. PubMed ID: 24302499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation effects on FAS1 domain 4 based on structure and solubility.
    Kim D; Chong SH; Shin S; Ham S
    Biochim Biophys Acta Proteins Proteom; 2022 Mar; 1870(3):140746. PubMed ID: 34942360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal Dystrophy Mutations Drive Pathogenesis by Targeting TGFBIp Stability and Solubility in a Latent Amyloid-forming Domain.
    Stenvang M; Schafer NP; Malmos KG; Pérez AW; Niembro O; Sormanni P; Basaiawmoit RV; Christiansen G; Andreasen M; Otzen DE
    J Mol Biol; 2018 Apr; 430(8):1116-1140. PubMed ID: 29524512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide Bond Pattern of Transforming Growth Factor β-Induced Protein.
    Lukassen MV; Scavenius C; Thøgersen IB; Enghild JJ
    Biochemistry; 2016 Oct; 55(39):5610-5621. PubMed ID: 27609313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAXS models of TGFBIp reveal a trimeric structure and show that the overall shape is not affected by the Arg124His mutation.
    Basaiawmoit RV; Oliveira CL; Runager K; Sørensen CS; Behrens MA; Jonsson BH; Kristensen T; Klintworth GK; Enghild JJ; Pedersen JS; Otzen DE
    J Mol Biol; 2011 May; 408(3):503-13. PubMed ID: 21371477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming growth factor-β-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates.
    Andreasen M; Nielsen SB; Runager K; Christiansen G; Nielsen NC; Enghild JJ; Otzen DE
    J Biol Chem; 2012 Oct; 287(41):34730-42. PubMed ID: 22893702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification and characterization of fourth FAS1 domain of TGFβIp-associated corneal dystrophic mutants.
    Elavazhagan M; Lakshminarayanan R; Zhou L; Ting LW; Tong L; Beuerman RW; Chaurasia SS; Mehta JS
    Protein Expr Purif; 2012 Jul; 84(1):108-15. PubMed ID: 22575305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies.
    Nielsen NS; Poulsen ET; Lukassen MV; Chao Shern C; Mogensen EH; Weberskov CE; DeDionisio L; Schauser L; Moore TCB; Otzen DE; Hjortdal J; Enghild JJ
    Prog Retin Eye Res; 2020 Jul; 77():100843. PubMed ID: 32004730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH Induced Conformational Transitions in the Transforming Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants.
    Murugan E; Venkatraman A; Lei Z; Mouvet V; Rui Yi Lim R; Muruganantham N; Goh E; Swee Lim Peh G; Beuerman RW; Chaurasia SS; Rajamani L; Mehta JS
    Sci Rep; 2016 Mar; 6():23836. PubMed ID: 27030015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
    Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
    Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.